ATE407710T1 - Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen - Google Patents

Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen

Info

Publication number
ATE407710T1
ATE407710T1 AT03762631T AT03762631T ATE407710T1 AT E407710 T1 ATE407710 T1 AT E407710T1 AT 03762631 T AT03762631 T AT 03762631T AT 03762631 T AT03762631 T AT 03762631T AT E407710 T1 ATE407710 T1 AT E407710T1
Authority
AT
Austria
Prior art keywords
implant
pharmacologically active
transport
release
active substances
Prior art date
Application number
AT03762631T
Other languages
English (en)
Inventor
Roman Denk
Original Assignee
Celonova Biosciences Germany G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celonova Biosciences Germany G filed Critical Celonova Biosciences Germany G
Application granted granted Critical
Publication of ATE407710T1 publication Critical patent/ATE407710T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Steroid Compounds (AREA)
AT03762631T 2002-07-05 2003-07-04 Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen ATE407710T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10230190 2002-07-05

Publications (1)

Publication Number Publication Date
ATE407710T1 true ATE407710T1 (de) 2008-09-15

Family

ID=30009809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762631T ATE407710T1 (de) 2002-07-05 2003-07-04 Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen

Country Status (13)

Country Link
EP (1) EP1534352B1 (de)
JP (1) JP2005532101A (de)
CN (1) CN1304062C (de)
AT (1) ATE407710T1 (de)
AU (2) AU2003246387A1 (de)
BR (1) BR0312453A (de)
CA (1) CA2491282C (de)
DE (1) DE60323510D1 (de)
DK (1) DK1534352T3 (de)
ES (1) ES2311733T3 (de)
PT (1) PT1534352E (de)
SI (1) SI1534352T1 (de)
WO (1) WO2004004795A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1432380T3 (da) 2001-08-17 2007-01-15 Polyzenix Gmbh Indretning baseret på nitrol med et overtræk af polyphosphazen
EP1605983B1 (de) * 2003-03-26 2011-01-05 CeloNova BioSciences Germany GmbH Beschichtete dentalimplantate
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
JP4885866B2 (ja) * 2004-10-25 2012-02-29 セロノヴァ バイオサイエンスィズ ジャーマニー ゲーエムベーハー 治療適用および／または診断適用のための充填可能なポリホスファゼン含有粒子、ならびにその調製方法および使用方法
JP2010533505A (ja) * 2006-10-10 2010-10-28 セロノバ バイオサイエンシーズ， インコーポレイテッド シリコーンおよび特定のポリホスファゼンを含む組成物およびデバイス
US8883190B2 (en) * 2006-12-01 2014-11-11 Wake Forest University Health Sciences Urologic devices incorporating collagen inhibitors
WO2009054851A1 (en) * 2007-10-24 2009-04-30 Celonova Biosciences, Inc. Specific polyphosphazene-containing three-dimensional bone support implants and mehods for their use
WO2009058145A1 (en) * 2007-10-31 2009-05-07 Celonova Biosciences, Inc. Vasodilator eluting luminal stent devices with a specific polyphosphazene coating and methods for their manufacture and use
WO2009058146A1 (en) * 2007-10-31 2009-05-07 Celonova Bioscience, Inc. Vasodilator eluting blood storage and administration devices with a specific polyphosphazene coating and methods for their manufacture and use
WO2009058147A1 (en) * 2007-10-31 2009-05-07 Celonova Biosciences, Inc. Loadable polymeric particles for therapeutic use in erectile dysfunction
CN102176868A (zh) * 2008-02-11 2011-09-07 西洛诺瓦生物科学公司 组织紧固物品和装置以及相关方法
EP2254605A4 (de) * 2008-02-22 2012-06-20 Celonova Biosciences Inc Multifunktionale wundverband-matrizen und relevante verfahren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1475611A1 (ru) * 1987-06-10 1989-04-30 Предприятие П/Я А-3697 Устройство дл соединени трубчатых органов
US4975280A (en) * 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
US6224626B1 (en) * 1998-02-17 2001-05-01 Md3, Inc. Ultra-thin expandable stent
CN1211130C (zh) * 2000-03-18 2005-07-20 保利詹尼克斯有限公司 具有抗菌性的聚磷腈衍生物及其应用
EP1274471B1 (de) * 2000-04-11 2007-01-03 Polyzenix GmbH Verwendung von Folien aus Poly-Tri-Fluor-Ethoxypolyphosphazenen zur Umhüllung von medizinischen Vorrichtungen
EP1179353A1 (de) * 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
DE50110900D1 (de) * 2000-11-21 2006-10-12 Schering Ag Röhrenförmige gefässimplantate (stents) sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CN1304062C (zh) 2007-03-14
SI1534352T1 (sl) 2009-02-28
EP1534352B1 (de) 2008-09-10
BR0312453A (pt) 2005-04-19
CA2491282C (en) 2013-02-12
EP1534352A1 (de) 2005-06-01
ES2311733T3 (es) 2009-02-16
DE60323510D1 (de) 2008-10-23
HK1080764A1 (en) 2006-05-04
CN1665550A (zh) 2005-09-07
DK1534352T3 (da) 2008-12-15
AU2010202360B2 (en) 2012-06-28
PT1534352E (pt) 2008-11-13
JP2005532101A (ja) 2005-10-27
AU2003246387A1 (en) 2004-01-23
CA2491282A1 (en) 2004-01-15
AU2010202360A1 (en) 2010-07-01
WO2004004795A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
NO20023933D0 (no) Nye forbindelser
NO20026064D0 (no) Nye forbindelser
DE60323510D1 (de) Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
IS2114B (is) Kínasólínafleiður til að meðhöndla æxli
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
ATE326466T1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
ATE386725T1 (de) Heterocyclylverbindungen
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
SE9902765D0 (sv) Novel compounds
CR7195A (es) Nuevos derivados de oxazolidinonas como antibacterianos
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
SE0101038D0 (sv) Novel compounds
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
CY1108482T1 (el) Συστημα υποδοριας διανομης, μεθοδος παρασκευης του και χρηση του για την αγωγη διαταραχων xολινεργικης ανεπαρκειας
BR0315837A (pt) Derivados de amida de ácido heteroaril-hexanóico como agentes imunomoduladores
SE9902551D0 (sv) Novel compounds
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DK1652836T3 (da) Aminosyrediamider i non-alfa-stilling, som egner sig som adjuvanser til administration af aktrive biologiske midler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1534352

Country of ref document: EP